relugolix
Selected indexed studies
- Relugolix/Estradiol/Norethisterone Acetate: A Review in Endometriosis-Associated Pain. (Drugs, 2024) [PMID:38592603]
- Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer. (N Engl J Med, 2020) [PMID:32469183]
- Treatment of Uterine Fibroid Symptoms with Relugolix Combination Therapy. (N Engl J Med, 2021) [PMID:33596357]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Relugolix/Estradiol/Norethisterone (Norethindrone) Acetate: A Review in Symptomatic Uterine Fibroids. (2022) pubmed
- Relugolix/Estradiol/Norethisterone Acetate: A Review in Endometriosis-Associated Pain. (2024) pubmed
- Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer. (2020) pubmed
- Treatment of Uterine Fibroid Symptoms with Relugolix Combination Therapy. (2021) pubmed
- Relugolix in the management of prostate cancer. (2022) pubmed
- Relugolix. (2012) pubmed
- Relugolix for the treatment of prostate cancer. (2024) pubmed
- Relugolix. (2006) pubmed
- Relugolix: A Review in Advanced Prostate Cancer. (2023) pubmed
- Relugolix+estradiol+norethisterone for symptomatic uterine fibroids. (2024) pubmed